Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01674829
What this trial is testing

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHABiotech CO., Ltd 10
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Not applicableUnknownNCT05763940
What this trial is testing

Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals

Who this might be right for
Dry Eye SyndromesAge-Related Macular DegenerationOmega 3 Index
Western University of Health Sciences 130
Large-scale testing (Phase 3)UnknownNCT00078221
What this trial is testing

Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
OccuLogix 180
Testing effectiveness (Phase 2)Study completedNCT00429936
What this trial is testing

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Sirion Therapeutics, Inc. 245
Not applicableStudy completedNCT03451578
What this trial is testing

Alpha MSH in Ocular Disease

Who this might be right for
Advanced Dry Macular Degeneration
Duke University 54
Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Early research (Phase 1)Looking for participantsNCT03178149
What this trial is testing

The Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT06018558
What this trial is testing

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Who this might be right for
Geographic Atrophy
Ocugen 60
Not applicableStudy completedNCT06174181
What this trial is testing

Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration

Who this might be right for
Dry Eye SyndromesAge-Related Macular Degeneration
Direction Centrale du Service de Santé des Armées 42
Not applicableStudy completedNCT05447650
What this trial is testing

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)

Who this might be right for
Age-Related Macular DegenerationDry Age-related Macular DegenerationNonexudative Age-related Macular Degeneration
i-Lumen Scientific, Inc. 95
Testing effectiveness (Phase 2)WithdrawnNCT04358471
What this trial is testing

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyGene Therapy+1 more
Hemera Biosciences
Not applicableStudy completedNCT03333954
What this trial is testing

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular Degeneration
Science Corporation 5
Not applicableLooking for participantsNCT06536062
What this trial is testing

Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Not applicableLooking for participantsNCT06662162
What this trial is testing

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationAge-related Macular Degeneration (ARMD)Intermediate AMD+1 more
i-Lumen Scientific AUS PTY LTD 100
Not applicableStudy completedNCT04084587
What this trial is testing

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Macular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more
University of Modena and Reggio Emilia 24
Not applicableUnknownNCT06582511
What this trial is testing

Evaluating Metabolic Changes Induced by PhotoBioModulation Through Spectrally Resolved Autofluorescence in Dry Age-Related Macular Degeneration Patients

Who this might be right for
Macular Degeneration, Age Related
Francesco Bandello 30
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Early research (Phase 1)Study completedNCT01003691
What this trial is testing

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Who this might be right for
Age-Related MaculopathyAge-Related MaculopathiesEye Diseases+2 more
Pfizer 24
Not applicableStudy completedNCT01712841
What this trial is testing

Non-exudative Age-related Macular Degeneration

Who this might be right for
Non-exudative Age-related Macular Degeneration
Oregon Health and Science University 30
Next Page